Herantis Pharma Oyj: Manager’s Transactions - Mats Heiman
Herantis Pharma Plc
Company release 13 March 2019 at 9:00 am
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Mats Heiman
Position: Closely associated person
(1):Person Discharging Managerial Responsibilities In Issuer
Name: Ingrid Atteryd Heiman
Position: Member of the Board
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20190312215059_9
____________________________________________
Transaction date: 2019-03-12
Venue not applicable
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: SUBSCRIPTION
Transaction details
(1): Volume: 10,000 Unit price: 5.2 EUR
Aggregated transactions
(1): Volume: 10,000 Volume weighted average price: 5.2 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com